Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of high-dose versus standard-dose dexamethasone in ARDS due to COVID-19
2020-005887-70Phase 2Completed
- Sponsor
- Fakultní nemocnice Brno
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dexamethasone in acute respiratory distress syndrome (ARDS) (2 arms), sponsored by Fakultní nemocnice Brno. Primary endpoint: Ventilator-free days at day 28. Started Jan 2021; status: completed.
02
Drugs
dexamethasone
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on 2020-005887-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005887-70.